Article · 10 Aug 2026
Research articlePublished 2016
EZH2 as a Therapeutic Target in Glioblastoma: A Cellular and Molecular Study
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Glioblastoma is the most common malignant brain tumor in adults and it is currently treated with a combination of surgery, radiotherapy and chemotherapy with temozolomide (TMZ). Many patients show resistance to TMZ, which is a challenge in the treatment of this type of brain cancer. New strategies are being tested, like the inhibition of EZH2, a histone methyltransferase which is overexpressed in cancer cells, leading to angiogenesis and metastasis. In this work, the EZH2 inhibitor DZNeP was tested in A172 glioblastoma cells and in A172-TMZ-resistant glioblastoma cells. Inhibition of cell proliferation, adhesion, colony formation, and migration was noted in control and TMZresistant glioblastoma cells after DZNeP treatment. At the level of EZH2 target gene expression, DZNeP decreased EZH2 expression, and increased the expression of its target genes (E-cadherin and TIMP3), which might probably contribute to inhibiting the development of a cancer metastatic phenotype. Finally, DZNeP negatively regulated the TGFβ pathway. In conclusion, we propose that inhibition of EZH2 might be considered as a therapeutic strategy against glioblastoma.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Carcinogenesis & Mutagenesis.
Article · 27 May 2026
The Role of Chemical Carcinogens in Human Carcinogenesis
Article · 27 May 2026
Environmental Mutagens: Mechanisms of Action and Preventive Strategies
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Carcinogenesis & Mutagenesis
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Javier de la Rosa”
- BylineArticles whose byline prints “Marta Iraburu”
- BylineArticles whose byline prints “Gabriel Gallo-Oller”
- BylineArticles whose byline prints “Mehdi H Shahi”
- BylineArticles whose byline prints “Bárbara Meléndez”
- BylineArticles whose byline prints “Juan A Rey”
- BylineArticles whose byline prints “Miguel A Idoate”
- BylineArticles whose byline prints “Javier S Castresana”